"Urea/therapeutic use"[MeSH] - Search Results

Year	Number of Results
1945	1
1947	1
1948	4
1949	2
1951	1
1952	1
1953	6
1954	5
1955	5
1956	5
1957	10
1958	9
1959	2
1961	3
1962	2
1963	1
1964	5
1965	80
1966	143
1967	193
1968	216
1969	237
1970	303
1971	421
1972	462
1973	478
1974	531
1975	465
1976	486
1977	437
1978	468
1979	421
1980	402
1981	403
1982	424
1983	394
1984	502
1985	407
1986	405
1987	381
1988	378
1989	374
1990	364
1991	409
1992	435
1993	378
1994	387
1995	469
1996	420
1997	447
1998	481
1999	435
2000	534
2001	483
2002	499
2003	562
2004	475
2005	500
2006	605
2007	598
2008	592
2009	599
2010	665
2011	777
2012	974
2013	1208
2014	1278
2015	1223
2016	1125
2017	1168
2018	1128
2019	1126
2020	1165
2021	1059
2022	920
2023	717
2024	717
2025	1

1

Development and Validation of a Sensitive LC-MS/MS Method for Determination of Lenvatinib and Its Major Metabolites in Human Plasma and Its Application in Hepatocellular Carcinoma Patients.

Guan S, Yuan G, Bi G, Yu Q, Fang JH, Chen J, Bi H. Guan S, et al. J Sep Sci. 2024 Dec;47(23):e70042. doi: 10.1002/jssc.70042. J Sep Sci. 2024. PMID: 39623559

2

Candidate genes in canine hepatocellular carcinoma for molecular targeted therapy.

Tanaka T, Motegi T, Mori M, Sumikawa N, Maeda K, Iimori Y, Akiyoshi H. Tanaka T, et al. BMC Res Notes. 2024 Dec 2;17(1):357. doi: 10.1186/s13104-024-07016-y. BMC Res Notes. 2024. PMID: 39623442 Free article.

3

Targeted agents in patients with progressive glioblastoma-A systematic meta-analysis of randomized clinical trials.

Ippen FM, Scherm A, Kessler T, Hau P, Agkatsev S, Baurecht H, Wick W, Knüttel H, Leitzmann MF, Seliger-Behme C. Ippen FM, et al. Cancer Med. 2024 Jun;13(12):e7362. doi: 10.1002/cam4.7362. Cancer Med. 2024. PMID: 39618405 Free article.

4

Effectiveness of sorafenib in treating intermediate-stage hepatocellular carcinoma patients refractory to transarterial chemoembolization.

Ashour R, Rewisha E, Rady MA, Elkhadry SW, Abdelhalim H, Atef M. Ashour R, et al. BMC Cancer. 2024 Nov 28;24(1):1466. doi: 10.1186/s12885-024-13199-1. BMC Cancer. 2024. PMID: 39609726 Free PMC article.

5

Population pharmacokinetic analysis of quizartinib in patients with newly diagnosed FLT3-internal-tandem-duplication-positive acute myeloid leukemia.

Vaddady P, Glatard A, Smania G, Nakayama S, Inoue H, Kurumaddali A, Abutarif M, Zheng M. Vaddady P, et al. Clin Transl Sci. 2024 Dec;17(12):e70074. doi: 10.1111/cts.70074. Clin Transl Sci. 2024. PMID: 39601658 Free PMC article. Clinical Trial.

6

Differential Effects of Landiolol in Patients with Atrial Fibrillation and Atrial Tachycardia.

Ayabe K, Komiyama T, Takekawa H, Kang H, Tsumagari Y, Ito M, Ashikaga K, Shibata Y. Ayabe K, et al. Medicina (Kaunas). 2024 Oct 31;60(11):1782. doi: 10.3390/medicina60111782. Medicina (Kaunas). 2024. PMID: 39596966 Free PMC article.

7

SOCS3 Methylation Partially Mediated the Association of Exposure to Triclosan but Not Triclocarban with Type 2 Diabetes Mellitus: A Case-Control Study.

Gao Q, Huan C, Jia Z, Cao Q, Yuan P, Li X, Wang C, Mao Z, Huo W. Gao Q, et al. Int J Mol Sci. 2024 Nov 11;25(22):12113. doi: 10.3390/ijms252212113. Int J Mol Sci. 2024. PMID: 39596180 Free PMC article.

8

Real-World, Observational, Retrospective Study to Evaluate the Effectiveness and Safety of Treatment with Sorafenib in Patients with Advanced Hepatocellular Carcinoma.

Csipak AR, da Fonseca LG, López RVM, Estevez-Diz MDP. Csipak AR, et al. Curr Oncol. 2024 Nov 1;31(11):6778-6790. doi: 10.3390/curroncol31110500. Curr Oncol. 2024. PMID: 39590131 Free PMC article.

9

Inhibition of soluble epoxide hydrolase reverses bone loss in periodontitis by upregulating EMCN and inhibiting osteoclasts.

Li J, Kou N, Shi X, Kong L, Chen W, Yang X, Zhao Y, Zhao J, Wang F. Li J, et al. Stem Cell Res Ther. 2024 Nov 25;15(1):451. doi: 10.1186/s13287-024-04054-y. Stem Cell Res Ther. 2024. PMID: 39587694 Free PMC article.

10

Intravenous glibenclamide for cerebral oedema after large hemispheric stroke (CHARM): a phase 3, double-blind, placebo-controlled, randomised trial.

Sheth KN, Albers GW, Saver JL, Campbell BCV, Molyneaux BJ, Hinson HE, Cordonnier C, Steiner T, Toyoda K, Wintermark M, Littauer R, Collins J, Lucas N, Nogueira RG, Simard JM, Wald M, Dawson K, Kimberly WT; CHARM Trial investigators. Sheth KN, et al. Lancet Neurol. 2024 Dec;23(12):1205-1213. doi: 10.1016/S1474-4422(24)00425-3. Lancet Neurol. 2024. PMID: 39577921 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31,949 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31,949 results

Results by year